WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 3'7801 Infant (under 12 months) mortality rate: 142
GDP / capita (US$): 7'9801 Child (under 5 years) mortality rate: 162

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 6'384  6'340  6'297  6'256  6'218  5'959  5'344  4'661 
Births 128  128  128  127  127  146  170  176 
Surviving infants 125  125  125  125  125  143  163  161 
Pop. less than 5 years 628  635  639  636  621  777  791  784 
Pop. less than 15 years 1'872  1'900  1'934  1'967  1'995  2'282  2'227  2'107 
Female 15-49 years 1'819  1'796  1'770  1'744  1'720  1'499  1'287  1'058 

Number of reported case

(Click for retrospective incidence data for El Salvador)
Diphtheria
Japanese encephalitis
Measles 2'315 
Mumps 257  274  351  632  369  1'170 
Pertussis 37  1'003 
Polio* 55 
Rubella 298 
Rubella (CRS)
Tetanus (neonatal) 25  61 
Tetanus (total)** 13  98 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for El Salvador)
Vaccine year result method % card seen                                                
BCG 2009  99  EPI   99  85  90  90  91  89  99  75  56 
DTP1 2009  97  EPI   99  96  91  92  90  90  87 
DTP3 2009  95  EPI   99  93  92  92  89  89  99  80  44 
DTP4          92 
IPV1         
HepB_BD          87  99* 
HepB3 2009  95  EPI   99  93  92  92  89  89  99 
Hib3 2009  95  EPI   99  93  92  92  89  89 
JapEnc         
MCV1          94  94  93  89  92  97  98  45 
MCV2          85  85  95  81  78 
PCV1          92  91  93  77 
PCV3          92  94  98  69 
Pol3 2009  96  EPI   99  93  92  93  90  89  98  80  42 
Rota1          97  92  93  90  90 
Rota_last          96  92  93  90  90 
Rubella1          94  94  93  89  91 
TT2plus          94  86  70  68  26 
PAB         
VAD1          47  57  10  42 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for El Salvador)
BCG 96  99  99  99  99  99  75  56 
DTP1 96  97  92  90  90  99  93  69 
DTP3 93  92  92  89  89  99  80  44 
HepB3 93  92  92  89  89  99 
HepB_BD
Hib3 93  92  92  89  89 
MCV1 94  94  93  89  92  97  98  45 
MCV2 85  85  95  81  78 
PAB 90  90  90  88  88  83  37  23 
PCV3 92  92  94  98  69 
Pol3 93  92  93  90  89  98  80  42 
Rota_last 96  92  93  90  90 

Number of districts in the country 262  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 59
From 80 to 89% 20
From 50 to 79% 19
Less than 50% 2
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT < 9 years; Yes allergic to pertussis
DTwP 4 years; Yes
DTwPHibHepB 2, 4, 6, 15 months; Yes
HepB_Adult Yes health care workers and risk groups
HepB_Pediatric birth; Yes
IPV Yes children with HIV+ mothers
Influenza_Adult >= 65 years; Yes and health care workers and pregnant women
Influenza_Pediatric 6 months to < 5 years; Yes and children with chronic diseases
MMR 1, 4 years; Yes
OPV 2, 4, 6, 18 months; 4 years; Yes
Pneumo_conj 2, 4, 12 months; Yes
Pneumo_ps >= 60 years; HCW and risk groups
Rotavirus 2, 4 months; Yes
Td Yes every 10 years and pregnant women
Tdap Yes pregnant women
VitaminA < 5 years; Yes
YF Travelers to endemic countries

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2013-2014  2009-2014  2009-2014  2009-2014  2009-2013    2004-2009 
Nº of districts with microplans that include activities to raise immunization coverage number 262  262  262  262  262  262  262 

System performance

Total Nº districts in country number 262  262  262      262  262 
Nº districts with DTP3 coverage >=80% number 207  216  221  202  185  224  224 
% of districts with DTP3 coverage >=80% From 0 to 100% 79  82  84      85  85 
Nº districts with measles (MCV1) coverage >=95% number 131  159  150  119  101  155  138 
% of districts with MCV1 coverage >=95% From 0 to 100% 50  61  57      59  53 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100  100  99  99  100  100  75 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.